Radioimmunotherapy for follicular lymphoma

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷 / 3期
关键词：
D O I：
10.1038/ncponc0117
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 120
相关论文
共 50 条
  • [21] RADIOIMMUNOTHERAPY OF (90Y)-IBRITUMOMAB TIUXETAN FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
    Yoshida, Isao
    Kogure, Yuuki
    Kajihara, Makoto
    ANNALS OF ONCOLOGY, 2014, 25
  • [22] Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
    Burack, W. Richard
    Li, Hongli
    Adlowitz, Diana
    Spence, Janice M.
    Rimsza, Lisa M.
    Shadman, Mazyar
    Spier, Catherine M.
    Kaminski, Mark S.
    Leonard, John P.
    Leblanc, Michael L.
    Smith, Sonali M.
    Friedberg, Jonathan W.
    BLOOD ADVANCES, 2023, 7 (17) : 5082 - 5090
  • [23] Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience
    Burnette, Brian L.
    Wiseman, Gregory
    Habermann, Thomas M.
    Macon, William R.
    Ansell, Stephen M.
    Inwards, David James
    Micallef, Ivana N.
    Johnston, Patrick B.
    Ristow, Kay M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    BLOOD, 2011, 118 (21) : 683 - 683
  • [24] Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma
    Fukuno, Kenji
    Tsurumi, Hisashi
    Yamada, Toshiki
    Iida, Takayoshi
    Takahashi, Takeshi
    Moriwaki, Hisataka
    LEUKEMIA & LYMPHOMA, 2013, 54 (12) : 2731 - 2733
  • [25] Results of a national consensus workshop:: therapeutic algorithm in patients with follicular lymphoma -: role of radioimmunotherapy
    Dreyling, M.
    Truemper, L.
    von Schilling, C.
    Rummel, M.
    Holtkamp, U.
    Waldmann, A.
    Wehmeyer, J.
    Freund, M.
    ANNALS OF HEMATOLOGY, 2007, 86 (02) : 81 - 87
  • [26] Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy
    M. Dreyling
    L. Trümper
    C. von Schilling
    M. Rummel
    U. Holtkamp
    A. Waldmann
    J. Wehmeyer
    M. Freund
    Annals of Hematology, 2007, 86 : 81 - 87
  • [27] Zevalin™ radioimmunotherapy of Rituximab-refractory follicular non-Hodgkin's lymphoma
    Witzig, TE
    White, CA
    Flinn, IW
    Gordon, L
    Emmanouilides, C
    Cripe, LD
    Saleh, M
    Czuczman, MS
    Wiseman, GA
    Spies, S
    Silverman, DH
    Burt, RW
    Olejnik, T
    Grillo-López, AJ
    BLOOD, 2000, 96 (11) : 507A - 507A
  • [28] RADIOIMMUNOTHERAPY IN FOLLICULAR NON-HODGKINS LYMPHOMA: TIME TREATMENT AND PREVIOUS THERAPEUTHIC APPROACHES EFFECTS
    Cascavilla, N.
    Scaramuzzi, M.
    La Sala, A.
    D'Arena, G.
    Mantuano, S.
    Carella, A. M.
    Greco, M. M.
    Merla, E.
    Iacobazzi, A.
    Dicembrino, F.
    Varraso, A. M.
    Capalbo, S.
    Guarini, A.
    Frusciante, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 649 - 649
  • [29] Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy
    Xie, Zhuoer
    Lasho, Terra
    Khurana, Arushi
    Ferrer, Alejandro
    Finke, Christy
    Mangaonkar, Abhishek A.
    Ansell, Stephen
    Fernandez, Jenna
    Shah, Mithun Vinod
    Al-Kali, Aref
    Gangat, Naseema
    Abeykoon, Jithma
    Witzig, Thomas E.
    Patnaik, Mrinal M.
    HAEMATOLOGICA, 2024, 109 (02) : 509 - 520
  • [30] Radioimmunotherapy, a new breakthrough in the treatment of follicular non-Hodgkin's lymphoma: The European perspective
    Chatal, JF
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (01) : 1 - 4
12345